Semaglutide is a long acting synthetic GLP-1 receptor agonist with a half-life of approximately 7 days, achieved through fatty acid chain conjugation enabling albumin binding and protection against DPP-4 enzymatic degradation. Hudson Science’s 5 pack format supplies five individually sealed 5mg lyophilized vials. Delivering 25mg total Semaglutide across matched batch vials, providing extended research supply continuity while maintaining the freshness and reconstitution flexibility advantages of individually sealed units over a single large volume vial.
The 5 pack format serves a distinct research procurement purpose from CSD’s single vial Semaglutide presentations. Each individually sealed 5mg vial is reconstituted only when required, preserving the integrity and potency of unused compound across the full protocol timeline. A meaningful advantage for extended weekly administration protocols consistent with Semaglutide’s 7 day half-life, where a single large reconstituted vial would face progressive degradation across the multi week usage period a 5 pack is designed to support. Given Semaglutide’s once weekly administration schedule referenced in clinical dosing guidelines, a 5 pack of 5mg vials naturally aligns with a multi week research protocol timeline from a single procurement.
Semaglutide’s pure GLP-1 receptor selectivity remains consistent across this 5 pack and CSD’s other Semaglutide presentations, prolonging the cyclic GMP independent incretin signal through glucose dependent insulin secretion, pancreatic glucagon suppression, gastric emptying delay, and hypothalamic satiety signaling. This positions it as the single receptor reference standard within CSD’s incretin research family, against which the dual GIP/GLP-1 and triple incretin agonist listings are compared in comparative receptor pathway research.
Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity across all five vials before being made available, with COA documentation available on request. CSD’s Semaglutide range now spans single vials, this 5 pack format, adjustable and fixed dose pens, and complete kits, giving researchers complete concentration, supply volume, and delivery format flexibility from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute individual vials with bacteriostatic water prior to use. Store lyophilized vials at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched alongside dual and triple incretin agonist compounds in comparative GLP-1 receptor pathway and metabolic activity studies. Browse CSD’s full peptide range for complete sourcing.
